ImmuCell Statistics Share Statistics ImmuCell has 9.04M
shares outstanding. The number of shares has increased by 15.37%
in one year.
Shares Outstanding 9.04M Shares Change (YoY) 15.37% Shares Change (QoQ) 1.41% Owned by Institutions (%) 13.46% Shares Floating 5.82M Failed to Deliver (FTD) Shares 515 FTD / Avg. Volume 1.83%
Short Selling Information The latest short interest is 19.19K, so 0.21% of the outstanding
shares have been sold short.
Short Interest 19.19K Short % of Shares Out 0.21% Short % of Float 0.26% Short Ratio (days to cover) 1.69
Valuation Ratios The PE ratio is -19.5 and the forward
PE ratio is -60.55.
ImmuCell's PEG ratio is
0.3.
PE Ratio -19.5 Forward PE -60.55 PS Ratio 1.59 Forward PS 3.1 PB Ratio 1.53 P/FCF Ratio -390.09 PEG Ratio 0.3
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for ImmuCell.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.41,
with a Debt / Equity ratio of 0.55.
Current Ratio 3.41 Quick Ratio 1.8 Debt / Equity 0.55 Debt / EBITDA 14.46 Debt / FCF -140.04 Interest Coverage -2.88
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $383.96K Profits Per Employee $-31.26K Employee Count 69 Asset Turnover 0.59 Inventory Turnover 2.61
Taxes Income Tax 10.06K Effective Tax Rate -0.47%
Stock Price Statistics The stock price has increased by 65.39% in the
last 52 weeks. The beta is 0.31, so ImmuCell's
price volatility has been higher than the market average.
Beta 0.31 52-Week Price Change 65.39% 50-Day Moving Average 6.54 200-Day Moving Average 5.28 Relative Strength Index (RSI) 54.81 Average Volume (20 Days) 28,079
Income Statement In the last 12 months, ImmuCell had revenue of 26.49M
and earned -2.16M
in profits. Earnings per share was -0.26.
Revenue 26.49M Gross Profit 7.94M Operating Income -1.64M Net Income -2.16M EBITDA 1.04M EBIT -1.62M Earnings Per Share (EPS) -0.26
Full Income Statement Balance Sheet The company has 3.76M in cash and 15.1M in
debt, giving a net cash position of -11.34M.
Cash & Cash Equivalents 3.76M Total Debt 15.1M Net Cash -11.34M Retained Earnings -14.16M Total Assets 45.62M Working Capital 12.05M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 357.9K
and capital expenditures -465.73K, giving a free cash flow of -107.82K.
Operating Cash Flow 357.9K Capital Expenditures -465.73K Free Cash Flow -107.82K FCF Per Share -0.01
Full Cash Flow Statement Margins Gross margin is 29.97%, with operating and profit margins of -6.19% and -8.14%.
Gross Margin 29.97% Operating Margin -6.19% Pretax Margin -8.1% Profit Margin -8.14% EBITDA Margin 3.94% EBIT Margin -6.19% FCF Margin -0.41%
Dividends & Yields ICCC does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for ICCC.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 25, 1990. It was a
backward
split with a ratio of 1:100.
Last Split Date Jul 25, 1990 Split Type backward Split Ratio 1:100
Scores Altman Z-Score 218.44 Piotroski F-Score 8
